Yüklüyor......
Current advances of targeting HGF/c-Met pathway in gastric cancer
Despite the advances in systemic chemotherapy, gastric adenocarcinoma (GC) remains the third most common cause of cancer-related deaths with poor prognosis. The heterogeneity of GC indicates that novel biomarkers should be established in order to further classify tumors and develop individual target...
Kaydedildi:
| Yayımlandı: | Ann Transl Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6046293/ https://ncbi.nlm.nih.gov/pubmed/30069449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.04.42 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|